Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2064]
News [3524]
Articles [160]
Editorials [3]
Conferences [127]
elearning [18]

Effective use of ibrutinib in the treatment of ABC lymphoma tumours

Dr Louis Staudt - National Cancer Institute, Bethesda, USA
Effective use of ibrutinib in the treatment of ABC lymphoma tumours ( Dr Louis Staudt - National Cancer Institute, Bethesda, USA )
1 May 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014

Reasons for combining immunotherapy with chemo to enhance anti tumour response

Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014

High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology

Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology ( Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands )
25 Mar 2014

Molecular pathways associated with immune modulation and thalidomide analogues

Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene
Molecular pathways associated with immune modulation and thalidomide analogues ( Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene )
25 Mar 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma

Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014

Critical insights on leukaemia and lymphoma from ASH 2013

Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014

Trial results at ASH 2013

Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA
Trial results at ASH 2013 ( Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA )
1 Jan 2014

Rituximab maintenance therapy and CLL treatment considerations going forward

Prof Ulrich Jäger - Medical University of Vienna, Austria
Rituximab maintenance therapy and CLL treatment considerations going forward ( Prof Ulrich Jäger - Medical University of Vienna, Austria )
1 Jan 2014

Oncotype DX: changing breast cancer treatment

Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA
Oncotype DX: changing breast cancer treatment ( Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA )
19 Dec 2013

Meeting the needs of the elderly, unfit CLL patient

Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Meeting the needs of the elderly, unfit CLL patient ( Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK )
19 Dec 2013

Improving outcomes in chronic lymphocytic leukaemia

Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany
Improving outcomes in chronic lymphocytic leukaemia ( Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany )
19 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation